Cidara Therapeutics (CDTX) Other Non-Current Assets: 2017-2025
Historic Other Non-Current Assets for Cidara Therapeutics (CDTX) over the last 9 years, with Sep 2025 value amounting to $23.6 million.
- Cidara Therapeutics' Other Non-Current Assets rose 1798.71% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 1798.71%. This contributed to the annual value of $96,000 for FY2024, which is 98.97% down from last year.
- As of Q3 2025, Cidara Therapeutics' Other Non-Current Assets stood at $23.6 million, which was up 272.07% from $6.3 million recorded in Q2 2025.
- Cidara Therapeutics' 5-year Other Non-Current Assets high stood at $23.6 million for Q3 2025, and its period low was $96,000 during Q4 2024.
- Over the past 3 years, Cidara Therapeutics' median Other Non-Current Assets value was $1.1 million (recorded in 2023), while the average stood at $4.7 million.
- In the last 5 years, Cidara Therapeutics' Other Non-Current Assets plummeted by 98.97% in 2024 and then soared by 5,994.23% in 2025.
- Quarterly analysis of 5 years shows Cidara Therapeutics' Other Non-Current Assets stood at $2.6 million in 2021, then slumped by 58.66% to $1.1 million in 2022, then spiked by 766.60% to $9.3 million in 2023, then crashed by 98.97% to $96,000 in 2024, then soared by 1,798.71% to $23.6 million in 2025.
- Its Other Non-Current Assets was $23.6 million in Q3 2025, compared to $6.3 million in Q2 2025 and $6.3 million in Q1 2025.